Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center

Jianquan Zhu; Yu Zhang; Meng Wang; Zhenfa Zhang; Dongsheng Yue; Shichang Liu; Yi Pan; Changli Wang

doi:10.12659/MSM.930738

11 August 2021 : Clinical Research

Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center

Jianquan Zhu^1ABCDEF, Yu Zhang^1BC, Meng Wang^1BC, Zhenfa Zhang^1BC, Dongsheng Yue^1BC, Shichang Liu^2BC, Yi Pan^3BC, Changli Wang^1AE*

DOI: 10.12659/MSM.930738

Med Sci Monit 2021; 27:e930738

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Export

Export Article Citation

Share via email

Share method:

Via email client program

Send me to my email

Content:

Title, authors, link

Title, authors, link, abstract

Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy